Guaifenesin Tablet, Extended Release
Product Images NDC 58602-853

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 58602-853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (600 mg (20 Tablet Label))

Package Label-principal Display Panel (600 mg (20 Tablet Label))
FDA Label Image

Package Label-principal Display Panel (600 mg (20 Tablet Carton Label))

Package Label-principal Display Panel (600 mg (20 Tablet Carton Label))
FDA Label Image

Package Label-principal Display Panel (600 mg Blister Carton (20 (1 x 20) Tablets))

Package Label-principal Display Panel (600 mg Blister Carton (20 (1 x 20) Tablets))
This is a medication called "Expectorant" sold in a package of 20 extended-release tablets. It claims to relieve chest congestion and thin and loosen mucus. The active ingredient in each tablet is Guath USP 600 g. It is in comparison with Mucinex® and the product was not manufactured or distributed by its distributor. It provides customer service information for more details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.